Vile R, Russell S J
Biology of Metastasis Laboratory, Imperial Cancer Research Fund, London, UK.
Gene Ther. 1994 Mar;1(2):88-98.
Gene therapy for cancer relies upon the delivery of a therapeutic gene to a target cell population which may comprise either the tumour cells themselves or specific host effector cells with anti-tumour activity. In addition, gene delivery may be targeted directly to the tumour cells in vivo or towards cells explanted from the patient. The precise requirements of the delivery system depend upon the specific therapeutic strategy being used. In each case, however, delivery must be accurate, efficient and must result in correctly regulated expression of the gene in only the desired cell type. Equally important, the delivery system must be safe for both the patient and the community as a whole. Here, we summarize the types of gene therapy which have been proposed for the treatment of cancer and review how currently available delivery systems are suited to each of these individual strategies.
癌症基因治疗依赖于将治疗性基因传递到靶细胞群体,该群体可能由肿瘤细胞本身或具有抗肿瘤活性的特定宿主效应细胞组成。此外,基因传递可以直接在体内靶向肿瘤细胞,也可以靶向从患者体内取出的细胞。传递系统的确切要求取决于所使用的具体治疗策略。然而,在每种情况下,传递都必须准确、高效,并且必须仅在所需的细胞类型中导致基因的正确调控表达。同样重要的是,传递系统对于患者和整个社会都必须是安全的。在这里,我们总结了已提出的用于治疗癌症的基因治疗类型,并回顾了当前可用的传递系统如何适用于这些个别策略中的每一种。